NCT02935959View on ClinicalTrials.gov

Premedication With Nebulized Ketamine,Dexmedetomidine Versus Midazolam in Oncologic Preschool Children

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

October 31, 2017

Conditions
Oncological Children
Interventions
DRUG

nebulized ketamine

Drugs will be prepared in 3 mL of saline 0.9% before administration by a standard hospital jet nebulizer via a mouthpiece, with a continuous flow of 100% oxygen at 6 L/min for 10 to 15 minutes (30 minutes before GA). Treatment will be stopped when the nebulizer began to sputter.

DRUG

nebulized Dexmedetomidine

DRUG

nebulized midazolam

Trial Locations (1)

171516

Assiut University, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02935959 - Premedication With Nebulized Ketamine,Dexmedetomidine Versus Midazolam in Oncologic Preschool Children | Biotech Hunter | Biotech Hunter